Sphere Power Inc.

A203690

KR7203690003

Personal Products

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
11,100 ^KRW	-1.60%		-8.26%	+9.25%

Mar. 27	Sangsangin Industry Co., Ltd. announced that it has received KRW 7.999999744 billion in funding from Sphere Power Inc.	CI
Mar. 26	Sangsangin Industry Co., Ltd. announced that it expects to receive KRW 7.999999744 billion in funding from Sphere Power Inc.	CI

Tranche Update on Prostemics Co., Ltd.'s Equity Buyback Plan announced on August 11, 2017.

February 19, 2018 at 01:43 am EST

From October 1, 2017 to December 31, 2017, the company has repurchased 3,000 shares, representing 0.006765% for KRW 11.17 million. With this, the company has completed the repurchase of 1,283,000 shares, representing 2.84% for KRW 3,306.78 million under the buyback announced on August 11, 2017.

Latest news about Sphere Power Inc.

Sangsangin Industry Co., Ltd. announced that it has received KRW 7.999999744 billion in funding from Sphere Power Inc.	Mar. 26	CI
Sangsangin Industry Co., Ltd. announced that it expects to receive KRW 7.999999744 billion in funding from Sphere Power Inc.	Mar. 25	CI
Sphere Power Inc. announced that it has received KRW 27.59999252 billion in funding from Spear Power Association, Betsupply No. 1 Investment Cooperative, Aseka Holdings Co., Ltd. and another investor	Dec. 20	CI
Sphere Power Inc. announced that it has received KRW 9.000004413 billion in funding	Nov. 16	CI
Sphere Power Inc. announced extension to the offering period	23-08-10	CI
Sphere Power Inc. announced extension to the offering period	23-07-11	CI
An unknown buyer agreed to acquire a 10.89% stake in Prostemics Co., Ltd. from Leaders Cosmetics Co., Ltd. for KRW 7.9 billion	23-06-22	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 11.999995778 billion in funding	23-06-22	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 999.995788 million in funding	23-06-22	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 23 billion in funding from Spear Power Association	23-05-30	CI
An unknown buyer entered into an agreement to acquire Egnis Inc. from Prostemics Co., Ltd. for KRW 1.5 billion.	23-05-29	CI
Prostemics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Prostemics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
Prostemics Co., Ltd. announced that it has received KRW 6 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	22-10-16	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	22-10-12	CI
Prostemics Co., Ltd.(KOSDAQ:A203690) dropped from S&P Global BMI Index	22-09-19	CI
Prostemics Co., Ltd. announced that it has received KRW 5 billion in funding	22-08-24	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 5 billion in funding	22-08-23	CI
Prostemics Co., Ltd. announced that it has received KRW 9.999997408 billion in funding	22-04-26	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 9.999997408 billion in funding	22-04-24	CI
Prostemics : California weed supplier HERBL in talks to go public via SPAC merger - sources	21-08-12	RE
Prostemics : California weed supplier HERBL in talks to go public via SPAC merger - sources	21-08-12	RE
Prostemics : Investors brace for annual Russell index rebalancing with pandemic imprint	21-06-21	RE
Prostemics : Investors brace for annual Russell index rebalancing with pandemic imprint	21-06-18	RE
Prostemics Co., Ltd. agreed to acquire OTKCNT Co., Ltd. from Icure Pharmaceutical Incorporation and Gang, Seok-Ho for KRW 17 billion.	20-08-05	CI

Chart Sphere Power Inc.

Duration

Period

More charts

Company Profile

Sphere Power Inc, formerly Prostemics Co Ltd, is a Korea-based company engaged in the business of manufacturing stem cell culture fluid cosmetics. The Company operates through two segments. The Household Health Business segment engages in weeding and sales of household wet wipes. The Bio Business segment is engaged in manufacturing and sales of cosmetics. In addition, this division is engaged in the bio business, such as the development of inflammatory bowel disease (IBD) treatment using microbiome exosomes, intestinal health functional food, and anticancer treatment.

Sector

Personal Products

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
SPHERE POWER INC.	+9.25%	100M
KAO CORPORATION	+10.09%	19.15B
GALDERMA GROUP AG	0.00%	17.54B
SHISEIDO COMPANY, LIMITED	-1.32%	10.84B
COTY INC.	-8.05%	10.22B
AMOREPACIFIC CORPORATION	+0.76%	6.53B
PROYA COSMETICS CO.,LTD.	+10.78%	6B
NATURA &CO HOLDING S.A.	-2.19%	4.41B
INTER PARFUMS, INC.	-18.05%	3.78B
INTERPARFUMS	-4.37%	3.58B